Upgrade to SI Premium - Free Trial

Alnylam Pharmaceuticals (ALNY) PT Raised to $300 at RBC Capital

August 2, 2024 6:21 AM
RBC Capital analyst Luca Issi raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $300.00 (from $265.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles